SANDOZ has announced it has received final approval for its third biosimilar, paving the way for the oncology therapy to be made available to patients across the European Union.
16/02/2009
NEW data from a meta-analysis of trials evaluating the addition of Merck KGaA’s Erbitux (cetuximab) to standard first-line chemotherapy in patients with non-small cell lung cancer (NSCLC) has been presented at the International Association for the Study of Lung Cancer’s 13th World Conference on Lung Cancer (WCLC) in San Francisco.
04/08/2009
RESEARCHERS at the University of Colorado’s School of Medicine have identified a gene which may be linked to the 20% fail rate of treating children with acute lymphoblastic leukaemia (ALL).
15/01/2009
THE COMMITTEE for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has adopted a negative opinion for the use of Erbitux (cetuximab) in combination with platinum-based chemotherapy for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, advanced or metastatic nonsmall cell lung cancer (NSCLC).
28/07/2009
US researchers have reported that when a tumour-penetrating peptide called iRGD was injected with several common chemotherapeutic drugs, it greatly increased the amount of drug reaching tumour cells in mice.
22/04/2010
THE UNITED Kingdom’s National Institute for Health and Clinical Excellence (NICE) has released a Final Appraisal Determination recommending the use of the drug Erbitux (cetuximab) in combination with chemotherapy as a first-line treatment for patients with metastatic colorectal cancer (mCRC).
04/06/2009
A PATIENT who was prescribed a course of anti-cancer drugs has lost his finger prints, causing him to be detained in the United States.
29/05/2009
ALFRED Health cancer patients will gain better access to life-saving cancer treatments thanks to a $1.2 million Brumby Labor Government funding boost.
23/07/2009
THE Blanchette Rockefeller Neurosciences Institute (BRNI) has received a green light from the FDA to enter Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients.
24/04/2009
PRIMA Biomed has secured $12m in funding to advance the commercialisation of the CVac ovarian cancer vaccine treatment product.
01/01/1980
RESEARCHERS at the Institut de recherches cliniques de Montréal (IRCM) have identified a molecule which increases the function of Natural Killer cells (NK cells).
21/01/2009
RESEARCHERS at the University of Michigan Comprehensive Cancer Centre have identified the gene ATDC which is over expressed in 90% of pancreatic cancers.
03/03/2009
AUSTRALIAN research published this week in The American Chemical Society’s Journal of Medicinal Chemistry describes a new radiopharmaceutical tracer which promises to give clearer pictures of melanoma and could lead to improved disease treatment.
08/10/2009
Patients in the US have received a bone marrow transplant using umbilical cord blood expanded by a patented 'off-the-shelf' mesenchymal precursor cells (MPCs).
27/11/2009
A STUDY released by the Translational Genomics Research Institute (TGen) has claimed cancer patients are able to survive longer under treatments based on their individual genetic profiles.
21/04/2009
PROFESSOR Chris O’Brien, Australia’s foremost head and neck surgeon has lost his fight with fight with brain cancer aged 57.
05/06/2009
PRODUCT labels on the class of drugs known as anti-EGFR monoclonal antibodies, specifically cetuximab (Erbitux) and panitumumab (Vectibix) have just been changed to no longer be recommended for the treatment colorectal cancers in patients with mutation KRAS.
04/08/2009
THE TRANSLATIONAL Genomics Research Institute (TGen) and Scottsdale Healthcare have announced two significant advances in treating lung cancer at the 13th World Conference on Lung Cancer in San Francisco.
11/08/2009
A NEW DRUG designed to “seek and destroy” common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.
06/10/2009